United States Devices for Inhaled Medications Market Report 2017

October 2017 | 122 pages | ID: U7FDAEEAC5CPEN
QYResearch

Abstracts

In this report, the United States Devices for Inhaled Medications market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Devices for Inhaled Medications in these regions, from 2012 to 2022 (forecast).

United States Devices for Inhaled Medications market competition by top manufacturers/players, with Devices for Inhaled Medications sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Consort Medical
• Inhalexper
• Cambridge Consultants
• Hovione
• Catalent, Inc
• VertMarkets, Inc
• Qualicaps
• 3M
• Aerovance
• AstraZeneca
• Boehringer Ingelheim
• Chiesi
• Cipla
• Civitas/Alkermes
• GlaxoSmithKline
• Hovione
• Mannkind
• Mantecorp
• Meda
• MicroDose Therapeutx
• Novartis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Dry Powder Inhalers
• Metered-Dose Inhalers
• Nebulizers
• Soft Mist Inhaler

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Devices for Inhaled Medications for each application, including

• Clinic
• Hospital
• Home

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Devices for Inhaled Medications Market Report 2017

1 DEVICES FOR INHALED MEDICATIONS OVERVIEW

1.1 Product Overview and Scope of Devices for Inhaled Medications
1.2 Classification of Devices for Inhaled Medications by Product Category
  1.2.1 United States Devices for Inhaled Medications Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Devices for Inhaled Medications Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Dry Powder Inhalers
  1.2.4 Metered-Dose Inhalers
  1.2.5 Nebulizers
  1.2.6 Soft Mist Inhaler
1.3 United States Devices for Inhaled Medications Market by Application/End Users
  1.3.1 United States Devices for Inhaled Medications Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Home
1.4 United States Devices for Inhaled Medications Market by Region
  1.4.1 United States Devices for Inhaled Medications Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Devices for Inhaled Medications Status and Prospect (2012-2022)
  1.4.3 Southwest Devices for Inhaled Medications Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Devices for Inhaled Medications Status and Prospect (2012-2022)
  1.4.5 New England Devices for Inhaled Medications Status and Prospect (2012-2022)
  1.4.6 The South Devices for Inhaled Medications Status and Prospect (2012-2022)
  1.4.7 The Midwest Devices for Inhaled Medications Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Devices for Inhaled Medications (2012-2022)
  1.5.1 United States Devices for Inhaled Medications Sales and Growth Rate (2012-2022)
  1.5.2 United States Devices for Inhaled Medications Revenue and Growth Rate (2012-2022)

2 UNITED STATES DEVICES FOR INHALED MEDICATIONS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Devices for Inhaled Medications Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Devices for Inhaled Medications Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Devices for Inhaled Medications Average Price by Players/Suppliers (2012-2017)
2.4 United States Devices for Inhaled Medications Market Competitive Situation and Trends
  2.4.1 United States Devices for Inhaled Medications Market Concentration Rate
  2.4.2 United States Devices for Inhaled Medications Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Devices for Inhaled Medications Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DEVICES FOR INHALED MEDICATIONS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Devices for Inhaled Medications Sales and Market Share by Region (2012-2017)
3.2 United States Devices for Inhaled Medications Revenue and Market Share by Region (2012-2017)
3.3 United States Devices for Inhaled Medications Price by Region (2012-2017)

4 UNITED STATES DEVICES FOR INHALED MEDICATIONS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Devices for Inhaled Medications Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Devices for Inhaled Medications Revenue and Market Share by Type (2012-2017)
4.3 United States Devices for Inhaled Medications Price by Type (2012-2017)
4.4 United States Devices for Inhaled Medications Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DEVICES FOR INHALED MEDICATIONS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Devices for Inhaled Medications Sales and Market Share by Application (2012-2017)
5.2 United States Devices for Inhaled Medications Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DEVICES FOR INHALED MEDICATIONS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Consort Medical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Inhalexper
  6.2.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cambridge Consultants
  6.3.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hovione
  6.4.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hovione Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Catalent, Inc
  6.5.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 VertMarkets, Inc
  6.6.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Qualicaps
  6.7.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 3M
  6.8.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 3M Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aerovance
  6.9.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Devices for Inhaled Medications Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim
6.12 Chiesi
6.13 Cipla
6.14 Civitas/Alkermes
6.15 GlaxoSmithKline
6.16 Hovione
6.17 Mannkind
6.18 Mantecorp
6.19 Meda
6.20 MicroDose Therapeutx
6.21 Novartis

7 DEVICES FOR INHALED MEDICATIONS MANUFACTURING COST ANALYSIS

7.1 Devices for Inhaled Medications Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Devices for Inhaled Medications

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Devices for Inhaled Medications Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Devices for Inhaled Medications Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DEVICES FOR INHALED MEDICATIONS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Devices for Inhaled Medications Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Devices for Inhaled Medications Sales Volume Forecast by Type (2017-2022)
11.3 United States Devices for Inhaled Medications Sales Volume Forecast by Application (2017-2022)
11.4 United States Devices for Inhaled Medications Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Devices for Inhaled Medications
Figure United States Devices for Inhaled Medications Market Size (K Units) by Type (2012-2022)
Figure United States Devices for Inhaled Medications Sales Volume Market Share by Type (Product Category) in 2016
Figure Dry Powder Inhalers Product Picture
Figure Metered-Dose Inhalers Product Picture
Figure Nebulizers Product Picture
Figure Soft Mist Inhaler Product Picture
Figure United States Devices for Inhaled Medications Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Devices for Inhaled Medications by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Home Examples
Table Key Downstream Customer in Home
Figure United States Devices for Inhaled Medications Market Size (Million USD) by Region (2012-2022)
Figure The West Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Devices for Inhaled Medications Sales (K Units) and Growth Rate (2012-2022)
Figure United States Devices for Inhaled Medications Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Devices for Inhaled Medications Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Devices for Inhaled Medications Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Devices for Inhaled Medications Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Devices for Inhaled Medications Sales Share by Players/Suppliers
Figure 2017 United States Devices for Inhaled Medications Sales Share by Players/Suppliers
Figure United States Devices for Inhaled Medications Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Devices for Inhaled Medications Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Devices for Inhaled Medications Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Devices for Inhaled Medications Revenue Share by Players/Suppliers
Figure 2017 United States Devices for Inhaled Medications Revenue Share by Players/Suppliers
Table United States Market Devices for Inhaled Medications Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Devices for Inhaled Medications Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Devices for Inhaled Medications Market Share of Top 3 Players/Suppliers
Figure United States Devices for Inhaled Medications Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Devices for Inhaled Medications Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Devices for Inhaled Medications Product Category
Table United States Devices for Inhaled Medications Sales (K Units) by Region (2012-2017)
Table United States Devices for Inhaled Medications Sales Share by Region (2012-2017)
Figure United States Devices for Inhaled Medications Sales Share by Region (2012-2017)
Figure United States Devices for Inhaled Medications Sales Market Share by Region in 2016
Table United States Devices for Inhaled Medications Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Devices for Inhaled Medications Revenue Share by Region (2012-2017)
Figure United States Devices for Inhaled Medications Revenue Market Share by Region (2012-2017)
Figure United States Devices for Inhaled Medications Revenue Market Share by Region in 2016
Table United States Devices for Inhaled Medications Price (USD/Unit) by Region (2012-2017)
Table United States Devices for Inhaled Medications Sales (K Units) by Type (2012-2017)
Table United States Devices for Inhaled Medications Sales Share by Type (2012-2017)
Figure United States Devices for Inhaled Medications Sales Share by Type (2012-2017)
Figure United States Devices for Inhaled Medications Sales Market Share by Type in 2016
Table United States Devices for Inhaled Medications Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Devices for Inhaled Medications Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Devices for Inhaled Medications by Type (2012-2017)
Figure Revenue Market Share of Devices for Inhaled Medications by Type in 2016
Table United States Devices for Inhaled Medications Price (USD/Unit) by Types (2012-2017)
Figure United States Devices for Inhaled Medications Sales Growth Rate by Type (2012-2017)
Table United States Devices for Inhaled Medications Sales (K Units) by Application (2012-2017)
Table United States Devices for Inhaled Medications Sales Market Share by Application (2012-2017)
Figure United States Devices for Inhaled Medications Sales Market Share by Application (2012-2017)
Figure United States Devices for Inhaled Medications Sales Market Share by Application in 2016
Table United States Devices for Inhaled Medications Sales Growth Rate by Application (2012-2017)
Figure United States Devices for Inhaled Medications Sales Growth Rate by Application (2012-2017)
Table Consort Medical Basic Information List
Table Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Consort Medical Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Inhalexper Basic Information List
Table Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Inhalexper Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Cambridge Consultants Basic Information List
Table Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Cambridge Consultants Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Hovione Basic Information List
Table Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hovione Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Hovione Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Hovione Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Catalent, Inc Basic Information List
Table Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Catalent, Inc Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table VertMarkets, Inc Basic Information List
Table VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure VertMarkets, Inc Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Qualicaps Basic Information List
Table Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Qualicaps Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table 3M Basic Information List
Table 3M Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3M Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure 3M Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure 3M Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Aerovance Basic Information List
Table Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aerovance Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure Aerovance Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure Aerovance Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Sales Growth Rate (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Sales Market Share in United States (2012-2017)
Figure AstraZeneca Devices for Inhaled Medications Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Chiesi Basic Information List
Table Cipla Basic Information List
Table Civitas/Alkermes Basic Information List
Table GlaxoSmithKline Basic Information List
Table Hovione Basic Information List
Table Mannkind Basic Information List
Table Mantecorp Basic Information List
Table Meda Basic Information List
Table MicroDose Therapeutx Basic Information List
Table Novartis Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Devices for Inhaled Medications
Figure Manufacturing Process Analysis of Devices for Inhaled Medications
Figure Devices for Inhaled Medications Industrial Chain Analysis
Table Raw Materials Sources of Devices for Inhaled Medications Major Players/Suppliers in 2016
Table Major Buyers of Devices for Inhaled Medications
Table Distributors/Traders List
Figure United States Devices for Inhaled Medications Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Devices for Inhaled Medications Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Devices for Inhaled Medications Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Type in 2022
Table United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Application in 2022
Table United States Devices for Inhaled Medications Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Devices for Inhaled Medications Sales Volume Share Forecast by Region (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume Share Forecast by Region (2017-2022)
Figure United States Devices for Inhaled Medications Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources